Annual ROE
-61.11%
+24.23%+28.39%
30 June 2024
Summary:
Renovaro Biosciences annual return on equity is currently -61.11%, with the most recent change of +24.23% (+28.39%) on 30 June 2024. During the last 3 years, it has fallen by -45.81% (-299.41%). RENB annual ROE is now -128.00% below its all-time high of 218.25%, reached on 01 March 2012.RENB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-104.63%
-22.11%-26.79%
30 September 2024
Summary:
Renovaro Biosciences quarterly return on equity is currently -104.63%, with the most recent change of -22.11% (-26.79%) on 30 September 2024. Over the past year, it has dropped by -31.87% (-43.80%). RENB quarterly ROE is now -112.69% below its all-time high of 824.30%, reached on 01 September 2016.RENB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.4% | -43.8% |
| 3 y3 years | -299.4% | -356.3% |
| 5 y5 years | -487.0% | -2246.0% |
RENB ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -299.4% | +60.9% | -356.3% | +32.4% |
| 5 y | 5 years | -789.5% | +60.9% | -2822.6% | +32.4% |
| alltime | all time | -128.0% | +92.3% | -112.7% | +93.1% |
Renovaro Biosciences ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -104.63%(+26.8%) |
| June 2024 | -61.11%(-28.4%) | -82.52%(-28.5%) |
| Mar 2024 | - | -115.40%(+42.0%) |
| Dec 2023 | - | -81.25%(+11.7%) |
| Sept 2023 | - | -72.76%(+14.5%) |
| June 2023 | -85.34%(-45.4%) | - |
| June 2023 | - | -63.53%(-58.9%) |
| Mar 2023 | - | -154.69%(+32.1%) |
| Dec 2022 | - | -117.06%(+24.2%) |
| Sept 2022 | - | -94.27%(+17.7%) |
| June 2022 | -156.20%(+920.9%) | -80.10%(+230.0%) |
| Mar 2022 | - | -24.27%(+5.8%) |
| Dec 2021 | - | -22.93%(+9.9%) |
| Sept 2021 | - | -20.87%(+29.5%) |
| June 2021 | -15.30%(+122.7%) | -16.12%(+96.1%) |
| Mar 2021 | - | -8.22%(+24.4%) |
| Dec 2020 | - | -6.61%(+14.2%) |
| Sept 2020 | - | -5.79%(-13.8%) |
| June 2020 | -6.87%(-34.0%) | -6.72%(+87.7%) |
| Mar 2020 | - | -3.58%(-19.7%) |
| Dec 2019 | - | -4.46%(-67.3%) |
| Sept 2019 | - | -13.64%(+17.2%) |
| June 2019 | -10.41%(+161.6%) | -11.64%(-17.1%) |
| Mar 2019 | - | -14.04%(-1.2%) |
| Dec 2018 | - | -14.21%(+152.4%) |
| Sept 2018 | - | -5.63%(-31.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | -3.98%(-97.2%) | -8.23%(-30.8%) |
| Mar 2018 | - | -11.90%(-92.2%) |
| Dec 2017 | - | -152.73%(-66.0%) |
| Sept 2017 | - | -449.40%(-213.0%) |
| June 2017 | -139.81%(-82.3%) | 397.64%(+58.5%) |
| Mar 2017 | - | 250.93%(-34.7%) |
| Dec 2016 | - | 384.48%(-53.4%) |
| Sept 2016 | - | 824.30%(-154.4%) |
| June 2016 | -789.21%(+218.0%) | -1515.55%(+464.9%) |
| Mar 2016 | - | -268.31%(+69.1%) |
| Dec 2015 | - | -158.64%(+42.1%) |
| Sept 2015 | - | -111.63%(-90.1%) |
| June 2015 | -248.20%(+264.5%) | - |
| Mar 2015 | - | -1125.12%(-538.5%) |
| Dec 2014 | -68.09%(-192.9%) | 256.61%(+224.3%) |
| Sept 2014 | - | 79.12%(+6.7%) |
| June 2014 | - | 74.14%(-2.4%) |
| Mar 2014 | - | 75.98%(+29.0%) |
| Dec 2013 | - | 58.91%(-17.4%) |
| Sept 2013 | - | 71.29%(+8.0%) |
| June 2013 | - | 66.00%(-34.5%) |
| Mar 2013 | 73.29%(-66.4%) | 100.74%(-12.9%) |
| Dec 2012 | - | 115.67%(-32.3%) |
| Sept 2012 | - | 170.78%(-33.8%) |
| June 2012 | - | 257.86%(-1.2%) |
| Mar 2012 | 218.25% | 260.87%(-5.2%) |
| Dec 2011 | - | 275.27% |
FAQ
- What is Renovaro Biosciences annual return on equity?
- What is the all time high annual ROE for Renovaro Biosciences?
- What is Renovaro Biosciences annual ROE year-on-year change?
- What is Renovaro Biosciences quarterly return on equity?
- What is the all time high quarterly ROE for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly ROE year-on-year change?
What is Renovaro Biosciences annual return on equity?
The current annual ROE of RENB is -61.11%
What is the all time high annual ROE for Renovaro Biosciences?
Renovaro Biosciences all-time high annual return on equity is 218.25%
What is Renovaro Biosciences annual ROE year-on-year change?
Over the past year, RENB annual return on equity has changed by +24.23% (+28.39%)
What is Renovaro Biosciences quarterly return on equity?
The current quarterly ROE of RENB is -104.63%
What is the all time high quarterly ROE for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly return on equity is 824.30%
What is Renovaro Biosciences quarterly ROE year-on-year change?
Over the past year, RENB quarterly return on equity has changed by -31.87% (-43.80%)